We have entered a golden age of biology, where AI tools can design novel molecules in minutes, functional tissues can be grown from stem cells, and human life can be extended. However, all of these innovations require scaling biomanufacturing and a massive gap remains. Traditional biomanufacturing platforms like CHO and E. coli are hindered by immense CAPEX requirements, slow infrastructure scaling, and biological bottlenecks - where creating a stable cell line alone can take upwards of 24 months. In this lightning talk, Future Fields introduces the EntoEngine™, a revolutionary biomanufacturing platform that replaces stainless steel tanks with the world’s most sophisticated multicellular bioreactor: Drosophila melanogaster. By moving beyond the tank, we eliminate the traditional trade-offs between speed, cost, quality, and protein complexity. We will showcase how the EntoEngine enables the predictable manufacturing of challenging proteins at a fraction of the time and cost of legacy systems. Discover how a decentralized, biology-first approach to manufacturing is essential to empowering the next generation of synthetic biology and reaching our goal of impacting one billion lives.